Kathryn E. Aziz

1.2k total citations · 1 hit paper
17 papers, 895 citations indexed

About

Kathryn E. Aziz is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kathryn E. Aziz has authored 17 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Kathryn E. Aziz's work include RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Radiation Therapy and Dosimetry (4 papers). Kathryn E. Aziz is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Radiation Therapy and Dosimetry (4 papers). Kathryn E. Aziz collaborates with scholars based in United States, Denmark and Canada. Kathryn E. Aziz's co-authors include Junjie Chen, Wenqi Wang, Xu Li, Zhen‐Dong Xiao, Boyi Gan, Randy L. Johnson, Sunil Krishnan, Jae‐Il Park, Lin Feng and Pierre D. McCrea and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Cancer Research.

In The Last Decade

Kathryn E. Aziz

16 papers receiving 890 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AMPK modulates Hippo pathway activity to regulate energy homeostasis

2015 433 citations Wenqi Wang, Zhen‐Dong Xiao et al. Nature Cell Biology profile →

Peers

Countries citing papers authored by Kathryn E. Aziz

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Aziz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Aziz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Aziz more than expected).

Fields of papers citing papers by Kathryn E. Aziz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Aziz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Aziz. The network helps show where Kathryn E. Aziz may publish in the future.

Co-authorship network of co-authors of Kathryn E. Aziz

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Aziz. A scholar is included among the top collaborators of Kathryn E. Aziz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Aziz. Kathryn E. Aziz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	732MO Circulating tumour DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study 2025 ·Annals of Oncology ·Emerik Österlund, (unknown), Andrew J. Pellatt, (unknown), (unknown), Christine M. Parseghian, Kathryn E. Aziz, Karla Alfaro, (unknown), Tsuyoshi Konishi, Michael J. Overman, (unknown), Jason Willis, (unknown), Kanwal Raghav, Timothy E. Newhook, Xiling Shen, Van K. Morris, (unknown), (unknown)	1
2	Copper oxide-based nanoparticles in agro-nanotechnology: advances and applications for sustainable farming 2025 ·Agriculture & Food Security ·(unknown), Kathryn E. Aziz	8
3	Biologic correlates of circulating tumor DNA (ctDNA) shedding in the INTERCEPT colorectal cancer (CRC) study. 2025 ·Journal of Clinical Oncology ·Emerik Österlund, (unknown), Andrew J. Pellatt, (unknown), Christine M. Parseghian, Kathryn E. Aziz, (unknown), (unknown), Ganiraju C. Manyam, Tsuyoshi Konishi, Michael J. Overman, Maria Pia Morelli, Jason Willis, John Paul Shen, Kanwal Pratap Singh Raghav, Timothy E. Newhook, Arvind Dasari, Anirban Maitra, Van K. Morris, (unknown)	1
4	Redefining the prognostic significance of RAS and BRAF V600E mutations on disease free survival in patients with colorectal cancer in the era of ct-DNA defined minimal residual disease: Results from the MD Anderson INTERCEPT Program. 2024 ·Journal of Clinical Oncology ·Andrew J. Pellatt, (unknown), (unknown), Christine M. Parseghian, Kathryn E. Aziz, (unknown), (unknown), (unknown), Ryan Huey, Abhineet Uppal, Tsuyoshi Konishi, Michael J. Overman, Maria Pia Morelli, Jason Willis, John Paul Shen, Kanwal Raghav, Timothy E. Newhook, Van K. Morris, Arvind Dasari, Scott Kopetz	0
5	INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort. 2024 ·Journal of Clinical Oncology ·(unknown), Andrew J. Pellatt, (unknown), Christine M. Parseghian, Kathryn E. Aziz, (unknown), (unknown), (unknown), Ryan Huey, Abhineet Uppal, Tsuyoshi Konishi, Michael J. Overman, Maria Pia Morelli, Jason Willis, John Paul Shen, Kanwal Raghav, Timothy E. Newhook, Van K. Morris, Arvind Dasari, Scott Kopetz	4
6	Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models 2021 ·Cancer Letters ·(unknown), (unknown), Sunil Krishnan, Kathryn E. Aziz, (unknown), Sarah Palackdharry, (unknown), Trisha M. Wise‐Draper, Gordon B. Mills, Susan E. Waltz, Vinita Takiar	70
7	Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers 2019 ·Scientific Reports ·Khaled Habiba, Kathryn E. Aziz, (unknown), (unknown), Lakshmi Shree Kulumani Mahadevan, Vladimir I. Makarov, Brad R. Weiner, Gerardo Morell, Sunil Krishnan	37
8	Radiation Therapy and Immunotherapy: What is the Optimal Timing or Sequencing? 2018 ·Immunotherapy ·Maureen Aliru, Jonathan E. Schoenhals, Bhanu Prasad Venkatesulu, (unknown), Hampartsoum B. Barsoumian, Ahmed Younes, Lakshmi Shree Kulumani Mahadevan, Melinda Soeung, Kathryn E. Aziz, James W. Welsh, Sunil Krishnan	48
9	Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles 2017 ·Scientific Reports ·(unknown), Sang Hyun Cho, Francisco J. Reynoso, Maureen Aliru, Kathryn E. Aziz, Monica H. Bodd, Xi Yang, Md Foiez Ahmed, (unknown), Nivedh Manohar, (unknown), Ramesh Tailor, Howard D. Thames, Sunil Krishnan	39
10	Gold nanotriangles: scale up and X-ray radiosensitization effects in mice 2017 ·Nanoscale ·Shanta Raj Bhattarai, Paul J. Derry, Kathryn E. Aziz, Pankaj Kumar Singh, (unknown), Awalpreet S. Chadha, Anton V. Liopo, Eugene R. Zubarev, Sunil Krishnan	56
11	Abstract 1065: MMP sensitive liposomes followed by radiotherapy improves tumor control in head and neck cancer mice models 2017 ·Cancer Research ·(unknown), (unknown), Rasmus Eliasen, Fredrik Melander, Awalpreet S. Chadha, Kathryn E. Aziz, Sunil Krishnan, Thomas L. Andresen	1
12	Targeted Gold Nanoparticles Enhance Radiation Effects in Pancreatic Tumor Models 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Maureen Aliru, Kathryn E. Aziz, Monica H. Bodd, (unknown), Lakshmi Shree Kulumani Mahadevan, Narayan Sahoo, (unknown), Sunil Krishnan	2
13	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family 2016 ·Molecular & Cellular Proteomics ·Xu Li, (unknown), Kathryn E. Aziz, Alexey V. Sorokin, Junjie Chen, Wenqi Wang	37
14	FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis 2016 ·Cell Reports ·Xu Li, Wenqi Wang, Yuanxin Xi, Min Gao, (unknown), Kathryn E. Aziz, Jun Qin, Wei Li, Junjie Chen	27
15	Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis 2015 ·Cancer Research ·Alexey V. Sorokin, Binoj C. Nair, Yongkun Wei, Kathryn E. Aziz, Valentina Evdokimova, Mien‐Chie Hung, Junjie Chen	21
16	FOXKs Promote Wnt/β-Catenin Signaling by Translocating DVL into the Nucleus 2015 ·Developmental Cell ·Wenqi Wang, Xu Li, Moonsup Lee, Sohee Jun, Kathryn E. Aziz, Lin Feng, My Tran, Nan Li, Pierre D. McCrea, Jae‐Il Park, Junjie Chen	110
17	AMPK modulates Hippo pathway activity to regulate energy homeostasis breakdown → 2015 ·Nature Cell Biology ·Wenqi Wang, Zhen‐Dong Xiao, Xu Li, Kathryn E. Aziz, Boyi Gan, Randy L. Johnson, Junjie Chen	433

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact